Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FYX38
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,623
Award facts
- Contract value 100% obligated
- $8,622.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical supply market while leveraging its small business status. The product will be delivered to the Park Ridge, Illinois location.
Xtandi is a prescription medication used in oncology treatment, consistent with DMS Pharmaceutical Group's established portfolio of supplying branded and generic prescription drugs to Department of Defense healthcare facilities nationwide. This delivery order is issued under the vendor's significant IDC with the DLA, valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility requirements. DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain reflects its sustained performance in delivering specialized medications and medical supplies to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FYX38?
SPE2DB25FYX38 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FYX38 worth?
The government has obligated $8,623 on SPE2DB25FYX38.
Is contract SPE2DB25FYX38 an order under another contract?
Yes. SPE2DB25FYX38 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX38 competed?
The extent of competition for SPE2DB25FYX38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award